These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 18833922

  • 1. [Management of acute lymphoblastic leukemia].
    Usui N.
    Rinsho Ketsueki; 2008 Oct; 49(10):1374-85. PubMed ID: 18833922
    [No Abstract] [Full Text] [Related]

  • 2. Adult ALL: where are we and where are we going?
    Larson RA.
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):342-4. PubMed ID: 16163203
    [No Abstract] [Full Text] [Related]

  • 3. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Caocci G, Vacca A, Ledda A, Murgia F, Piras E, Greco M, Arras M, Atzeni S, Littera R, La Nasa G.
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733
    [No Abstract] [Full Text] [Related]

  • 4. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Shin HJ, Chung JS, Cho GJ.
    Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
    Herold R, von Stackelberg A, Hartmann R, Eisenreich B, Henze G.
    J Clin Oncol; 2004 Feb 01; 22(3):569-70; author reply 570-1. PubMed ID: 14752084
    [No Abstract] [Full Text] [Related]

  • 9. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
    IMAHASHI N, TOKUNAGA M, NISHIWAKI S, YANAGISAWA M, OZAWA Y, MIYAMURA K.
    Rinsho Ketsueki; 2009 Nov 01; 50(11):1612-5. PubMed ID: 20009435
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Millot F, Cividin M, Brizard F, Chomel JC, Méchinaud F, Guilhot F.
    Pediatr Blood Cancer; 2009 Jul 01; 52(7):891-2. PubMed ID: 19202569
    [Abstract] [Full Text] [Related]

  • 12. Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is not necessary, at least in induction.
    Chiaretti S.
    Clin Adv Hematol Oncol; 2016 Nov 01; 14(11):892-896. PubMed ID: 27930641
    [No Abstract] [Full Text] [Related]

  • 13. Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation.
    Conchon M, Sanabani SS, Bendit I, Serpa M, Filho UA, de Barros Ferreira P, Novaes MM, Saboya R, Llacer-Dorliac PE, Dulley FL.
    Bone Marrow Transplant; 2010 Jun 01; 45(6):1125-6. PubMed ID: 19855440
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Acute lymphoblastic leukemia and chronic lymphocytic leukemia in adults].
    Usui N.
    Rinsho Ketsueki; 2012 Feb 01; 53(2):164-75. PubMed ID: 22450575
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
    Fruehauf S, Topaly J, Buss EC, Schad M, Goerner M, Zeller WJ, Ho AD.
    Haematologica; 2002 Dec 01; 87(12):ECR38. PubMed ID: 12495909
    [No Abstract] [Full Text] [Related]

  • 18. Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Fagioli F, Zecca M, Rognoni C, Lanino E, Balduzzi A, Berger M, Messina C, Favre C, Rabusin M, Lo Nigro L, Masetti R, Prete A, Locatelli F, AIEOP-HSCT Group.
    Biol Blood Marrow Transplant; 2012 Jun 01; 18(6):852-60. PubMed ID: 22019726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dasatinib after allogeneic stem cell transplantation in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    de Castro CG, Gregianin LJ, Meneses CF, Brunetto AL.
    Pediatr Blood Cancer; 2009 Dec 01; 53(6):1161. PubMed ID: 19621456
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.